Tianda Pharmaceuticals (HKSE:00455) Short-Term Debt : HK$96.5 Mil (As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

What is Tianda Pharmaceuticals Short-Term Debt?

Tianda Pharmaceuticals's Short-Term Debt for the quarter that ended in Dec. 2023 was HK$96.5 Mil.

Tianda Pharmaceuticals's quarterly Short-Term Debt increased from Sep. 2022 (HK$51.7 Mil) to Jun. 2023 (HK$70.2 Mil) and increased from Jun. 2023 (HK$70.2 Mil) to Dec. 2023 (HK$96.5 Mil).

Tianda Pharmaceuticals's annual Short-Term Debt increased from Mar. 2021 (HK$18.9 Mil) to Mar. 2022 (HK$57.3 Mil) and increased from Mar. 2022 (HK$57.3 Mil) to Dec. 2023 (HK$96.5 Mil).

Tianda Pharmaceuticals Short-Term Debt Historical Data

The historical data trend for Tianda Pharmaceuticals's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianda Pharmaceuticals Short-Term Debt Chart

Tianda Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

0.61

18.89

57.26

96.49

Tianda Pharmaceuticals Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Jun23	Dec23
Short-Term Debt	Get a 7-Day Free Trial															20.36	57.26	51.69	70.20	96.49

Tianda Pharmaceuticals Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Tianda Pharmaceuticals Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Tianda Pharmaceuticals's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianda Pharmaceuticals (HKSE:00455) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianda Pharmaceuticals Ltd (HKSE:00455) » Definitions » Short-Term Debt

Traded in Other Exchanges

N/A

Address

CITIC Tower, No. 1 Tim Mei Avenue, Suites 2405-2410, 24th Floor, Central, Hong Kong, HKG

Website

https://www.tiandapharma.com

Tianda Pharmaceuticals Ltd is engaged in R&D, manufactures and sales of pharmaceutical, biotechnology and healthcare products. The group also engages in R&D of Chinese medicine and manufacture and sales of Chinese medicine products, and the provision of Chinese medical services. Its operating segments include Chinese medicine business; Medical and healthcare services; and Pharmaceuticals and medical technologies business. The company derives majority of the revenue from Pharmaceuticals and medical technologies business.

Executives

Tianda Group Limited	2101 Beneficial owner
Fang Wen Quan	2201 Interest of corporation controlled by you

Tianda Pharmaceuticals (HKSE:00455) Headlines

No Headlines